Applied Dna Sciences (NASDAQ:BNBX) Announces Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) released its earnings results on Thursday. The company reported ($0.57) EPS for the quarter, FiscalAI reports. The business had revenue of $0.61 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.

Applied Dna Sciences Stock Down 4.1%

Shares of NASDAQ:BNBX traded down $0.01 during trading on Friday, reaching $0.14. The stock had a trading volume of 7,055 shares, compared to its average volume of 484,386. The stock has a fifty day simple moving average of $0.28 and a two-hundred day simple moving average of $0.54. The firm has a market capitalization of $974,473.80, a price-to-earnings ratio of -0.00 and a beta of 0.60. Applied Dna Sciences has a 52 week low of $0.07 and a 52 week high of $7.15.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.